(Q31399132)

English

Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

E Vieta

4

0 references

author name string

J A Sacristán

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

J C Gómez

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

A L Montejo

3

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

K J Gregor

5

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

583-599

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Can overall results of clinical trials be applied to all patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Content and quality of 2000 controlled trials in schizophrenia over 50 years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A plea for the ?naturalistic? study of medicines

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of risperidone and olanzapine in outpatient clinics at six Veterans Affairs hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug utilisation studies as tools in health economics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980046-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(00)80046-6

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31399132&oldid=1988991452"